Merck & Co., Inc. (MRK) closed at $148.74 on September 26, 2026, a gain of 0.50% from the prior session. The advance extended a modest week-long recovery, with the stock up 1.36% over the past seven days.
Despite the near-term uptick, the broader 30-day trend tells a more cautious story. MRK has shed 2.87% over that stretch, keeping the stock under pressure even as it claws back ground in recent sessions.
Merck's market capitalization stood at $365.09 billion as of the close, reflecting its position as one of the larger companies in the pharmaceutical sector. The gap between the short-term bounce and the month-long decline suggests the stock has yet to fully recover from the selling that defined much of the past four weeks.
Trading activity on the day aligned with the modest price movement, as MRK continued to consolidate within its recent range. Whether the one-week upswing can offset the broader monthly pullback remains an open question heading into the final days of September.
